About BrainCells
BrainCells develops and provides biopharmaceutical products for the treatment of central nervous system (CNS) diseases. It develops compounds that promote the growth of new neurons for the treatment of major depressive disorder (MDD), treatment resistant depression (TRD), and potentially Alzheimer’s disease (AD). The company's products include BCI-838 and BCI-632 which increase synaptic glutamate by inhibiting the mGlu2/3 auto-receptor. The company also builds a pipeline of clinical-stage programs to address unmet medical needs in the treatment of mood disorders, psychoses, cognition, brain repair syndromes, and other CNS disorders. The company was founded in 2003 and is based in San Diego, California.
|
|
|
11-50 employees
View all BrainCells employees
|
|
Medical Equipment Manufacturing
|
|
858 812 7700
|
|
San Diego, California
|
|
2003
|
BrainCells Alternatives
Frequently Asked Questions about BrainCells
The decision makers in BrainCells are Andrea Bennett, Ivor Breukink, Jeff Champtaloup, etc. Click to Find BrainCells decision makers emails.
BrainCells Staff Directory
Search BrainCells Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
